Mosaic ImmunoEngineering Inc (CPMV)

[Poker MVP]

If TPL manages to settle and/or acquire additional licensing agreements, compounded with possible royalty payments from AMD & INTC, and with Pohl’s recent statement of “no debt other than current payables, and millions of tax loss carry forward to apply against future earnings as permitted applicable laws...” I would imagine ROCE to be much, much higher than 4% for this fiscal year and beyond [especially if PTSC manages to suppress liabilities for the next 10 years].